首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Leukemia research reports

缩写:

ISSN:2213-0489

e-ISSN:

IF/分区:0.8/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引541条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Chana L Glasser Chana L Glasser
Tumor Lysis Syndrome (TLS) is a well-known complication of induction therapy for hematologic malignancies. It is characterized by rapid breakdown of malignant white blood cells (WBCs) leading to metabolic derangements and serious morbidity ...
Yi Yang,Heather Wickless Yi Yang
To determine some of the key clinical features that help prompt clinicians to pursue additional work-up for evaluation of CNS involvement of MF, we conducted a systematic review to better define characteristics, treatments, outcomes, and mo...
Sarah M Choi,Ben Goldenson,Lo Ann Peterson et al. Sarah M Choi et al.
While growing use of comprehensive mutational analysis has led to the discovery of innumerable genetic alterations associated with various myeloid neoplasms, the under-recognized phenomenon of genetic heterogeneity within such neoplasms cre...
Nicola Orofino,Daniele Cattaneo,Cristina Bucelli et al. Nicola Orofino et al.
Myeloid Sarcoma (MS) is a rare malignancy that can present as an isolated disease or more frequently in association with or following acute myeloid leukemia or other myeloid neoplasms and rarely following myelofibrosis. Since molecular path...
Sheenu Sheela,Sawa Ito,Jeffrey R Strich et al. Sheenu Sheela et al.
Disseminated Fusarium infection is associated with high mortality in immunocompromised patients. Patients with acute myeloid leukemia (AML) often have an extended duration of neutropenia during intensive induction chemotherapy, consolidatio...
Satoko Oka,Masaharu Nohgawa Satoko Oka
Thrombotic thrombocytopenic purpura (TTP) is rare but life-threatening disease, characterized typically by microangiopathic hemolytic anemia (MAHA), profound peripheral thrombocytopenia and severe deficiency in the von Willebrand factor-cle...
Prachi Jain,Jeffrey Klotz,Neil Dunavin et al. Prachi Jain et al.
Patients with high risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are commonly older with multiple co-morbidities, rendering them unsuitable for intensive induction chemotherapy or transplantation. We report preli...
Pankit Vachhani,Sarah Shin,Jeffrey Baron et al. Pankit Vachhani et al.
Anthracyclines constitute the backbone of intensive adult acute myeloid leukemia (AML) therapy. Cardiotoxicity is one of its most serious adverse effects, and its incidence increases with cumulative dose. Dexrazoxane is a cardioprotective a...
Seiichiro Katagiri,Tetsuzo Tauchi,Keiko Ando et al. Seiichiro Katagiri et al.
It is difficult to predict musculoskeletal pain as a withdrawal syndrome following the discontinuation of imatinib (IM) in patients with chronic myeloid leukemia. We investigated a link between physical size and musculoskeletal pain followi...